Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684. (Q42727617)
Jump to navigation
Jump to search
scientific article published on December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684. |
scientific article published on December 2011 |
Statements
1 reference
Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684. (English)
1 reference
Ruth H Palmer
1 reference
Bengt Hallberg
1 reference
Kristina Ruuth
1 reference
Therese Eriksson
1 reference
Christina Schönherr
1 reference
Yasuo Yamazaki
1 reference
James Christensen
1 reference
1 December 2011
1 reference
1 reference
440
1 reference
3
1 reference
405-413
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference